Medexus Pharmaceuticals Inc
TSX:MDP
Medexus Pharmaceuticals Inc
TSX:MDP
Price:
1.6 CAD
-1.23%
Market Closed
Updated:
May 19, 2024
Medexus Pharmaceuticals Inc
Operating Expenses
|
Medexus Pharmaceuticals Inc
Operating Expenses Peer Comparison
Comparables:
BHC
WEED
SNDL
CRON
C
CURA
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
Operating Expenses
-$48.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-26%
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Operating Expenses
-$4.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-4%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Operating Expenses
-CA$298.7m
|
CAGR 3-Years
27%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Operating Expenses
-CA$281.4m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Operating Expenses
-$91.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Operating Expenses
-$1B
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-391%
|
CAGR 10-Years
N/A
|
See Also
What is Medexus Pharmaceuticals Inc's Operating Expenses?
Operating Expenses
-48.4m
USD
-48.4m
USD
Based on the financial report for Dec 31, 2023, Medexus Pharmaceuticals Inc's Operating Expenses amounts to -48.4m USD.
What is Medexus Pharmaceuticals Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-26%
-26%
Over the last year, the Operating Expenses growth was 5%. The average annual Operating Expenses growth rates for Medexus Pharmaceuticals Inc have been 2% over the past three years , -29% over the past five years , and -26% over the past ten years .
You don't have any saved screeners yet
